Berkeley Catalyst Fund (BCF) is an investment Firm.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
The Berkeley Catalyst Fund (BCF) provides benefits to entrepreneurial startups and helps foster the vibrant startup ecosystem around the UC systems located in the San Francisco Bay Area. BCF invests primarily in Seed and Series A stage private companies.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
10/2021 | Akadeum Life Sciences | Series B | 0 |
3/2020 | SwineTech | Series A | 0 |
1/2023 | Telesair | Series A | 22M |
10/2022 | Valitor | Series B | 0 |
8/2020 | Syntegra | Seed Round | 0 |
9/2018 | Valitor | Series A | 0 |
4/2020 | Nelumbo | Series A | 14M |
7/2022 | Vicinitas Therapeutics | Series A | 65M |
12/2020 | PrinterPrezz | Series A | 16M |
3/2021 | Amplicore | Seed | 4M |
3/2022 | Arima Genomics | Series B | 0 |
3/2020 | Circle Pharma | Series B | 0 |
1/2021 | Resilient Biotics | Series A | 7.2M |
7/2018 | Nelumbo | Series A | 0 |
8/2018 | DNALite Therapeutics | Seed Round | 0 |
4/2017 | LogicInk | Pre Seed Round | 1M |
9/2021 | Acrigen Biosciences | Seed Round | - |
8/2018 | Newomics | Series A | 3.9M |
6/2020 | 4D Molecular Therapeutics | Series C | 0 |
2/2020 | Arima Genomics | Series A | - |
12/2020 | Newomics | Series B | 0 |
12/2019 | Akadeum Life Sciences | Series A | - |
7/2022 | Vicinitas Therapeutics | Series A | 0 |
3/2022 | Arima Genomics | Series B | 0 |
10/2021 | Akadeum Life Sciences | Series B | 0 |
9/2021 | Acrigen Biosciences | Seed Round | - |
3/2021 | Amplicore | Seed Round | 0 |
1/2021 | Resilient Biotics | Series A | 0 |
12/2020 | PrinterPrezz | Series A | 0 |
12/2020 | Newomics | Series B | 0 |
8/2020 | Syntegra | Seed Round | 0 |
6/2020 | 4D Molecular Therapeutics | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|